Abstract
A 41-year-old woman received a syngeneic BMT for CLL and subsequently developed acute skin GVHD. Transfusion-related allogeneic GVHD was excluded on the basis of an unchanged HLA type in circulating lymphocytes. Short tandem repeat PCR was used to confirm syngeneicity between donor and recipient. The patient had a personal and family history of autoimmune disease which may have made her particularly susceptible to development of syngeneic GVHD. The distinction between allogeneic and syngeneic or autologous GVHD is important because of therapeutic implications.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Deane, M., Singer, C., Lawler, M. et al. Acute skin GVHD following syngeneic BMT for CLL. Bone Marrow Transplant 22, 1207–1209 (1998). https://doi.org/10.1038/sj.bmt.1701515
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1701515
Keywords
This article is cited by
-
Graft-versus-leukemia in chronic lymphocytic leukemia
Bone Marrow Transplantation (2007)
-
Syngeneic graft-versus-host disease: a report of two cases and literature review
Bone Marrow Transplantation (2003)